稳心颗粒联合倍他乐克治疗冠心病心律失常疗效观察

Observation on curative effect of wenxinkeli combined with metoprolol in the treatment of coronary heart disease with arrhythmia

目的探讨稳心颗粒联合倍他乐克治疗冠心病心律失常的临床效果。方法将2008-06～2011-06收治的冠心病心律失常患者160例,随机分为观察组和对照组各80例。观察组使用稳心颗粒联合倍他乐克治疗,对照组使用心律平治疗,观察两组患者药物治疗效果并进行比较分析。结果观察组的疗效和总有效率均优于对照组(P<0.01)。结论稳心颗粒联合倍他乐克治疗冠心病心律失常疗效显著、副作用小、并发症少,但是临床用药应该考虑到患者的心功能和有无其他合并症等实际情况,注意用药个体化及避免滥用。

Objective To investigate the curative effect of coronary heart disease with arrhythmia treated with wensinkeli combined with metoprolol. Methods One hun＆end and sixty patients with coronary heart disease complicated with arrhythmia treated in our hospital from June 2008 to June 2011 were randomly divided into observation group （n = 80） and control group （ n = 80）. The observation group were treated with wenxinkeli combined with metoprolol, while the control group were treated with propafenone. The clinical effects of the two groups were observed, compared and then analyzed. Results The curative effects and total effective rate of the observation group were higher than those of the control group （ P 〈 0. 01 ）. Conclusion Wenxinkeli combined with metoprolol has a good clinical effect for treatment of coronary heart disease with arrhythmia. The side effect and complications are low. However, in clinical use of drugs we should take the patients＇ heart function, complications and the actual situation into account, emphasizing the individual and avoiding drug abuse.